Sponsor or institution
Clinical trials and research at Shantou University Medical College
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Shantou University Medical College that are recruiting, in China. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Tracking immune-related side effects in people with solid tumors starting immunotherapy | — | Fuzhou, Fujian and 5 other locations | Recruiting | Jan 22, 2026 |
| Intestinal Low-Dose Radiotherapy plus Immunochemotherapy to Convert Borderline Resectable or Unresectable Esophageal Squamous Cell Carcinoma | Phase 2 | Shantou, Guangdong | Recruiting | Jan 14, 2026 |
| Low-dose intestinal radiation plus immunotherapy for immune-resistant metastatic solid cancers | Phase 2 | Shantou, Guangdong | Recruiting | Jul 17, 2025 |
| Exploring biomarkers to predict tumor response to radiotherapy | — | Shantou, Guangdong | Recruiting | Nov 16, 2018 |
All recruiting trials (4)
-
Tracking immune-related side effects in people with solid tumors starting immunotherapy
We will follow adults with solid tumors beginning immune checkpoint inhibitors to see if blood, tissue, and other tests can predict or explain immune-related side effects, with special attention to neurological problems.
-
Intestinal Low-Dose Radiotherapy plus Immunochemotherapy to Convert Borderline Resectable or Unresectable Esophageal Squamous Cell Carcinoma
This study tests whether adding a very low dose intestinal radiotherapy with immunochemotherapy can make advanced esophageal squamous cell carcinoma operable for patients who can’t be surgically removed today.
-
Low-dose intestinal radiation plus immunotherapy for immune-resistant metastatic solid cancers
This trial tests whether giving small doses of radiation to the intestine together with PD‑1/PD‑L1 immunotherapy can help people whose metastatic solid tumors have stopped responding to checkpoint inhibitors.
-
Exploring biomarkers to predict tumor response to radiotherapy
This study is trying to find markers in tumors and blood that can help predict how well solid tumors will respond to radiotherapy in patients who need this treatment.
Quick answers
How many clinical trials run by Shantou University Medical College are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.